These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33852723)

  • 1. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
    Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
    Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
    Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J
    Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating insulin growth-like factor 1 and insulin growth-like factor binding protein 3 in renal cell carcinoma patients.
    Tsai CW; Chang WS; Xu Y; Huang M; Tamboli P; Wood CG; Bau DT; Gu J
    Am J Cancer Res; 2022; 12(2):852-860. PubMed ID: 35261807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
    Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
    Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
    Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
    Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
    Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
    Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
    Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita HB; Cohn BA; Deschasaux-Tanguy M; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Haiman CA; Hankey GJ; Holly JMP; Huang J; Huang WY; Hurwitz LM; Kaaks R; Kubo T; Le Marchand L; MacInnis RJ; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Pollak MN; Roobol MJ; Schaefer CA; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Touvier M; Van Den Eeden SK; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; ; Allen NE; Key TJ; Travis RC
    Int J Epidemiol; 2023 Feb; 52(1):71-86. PubMed ID: 35726641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
    Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
    Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically predicted high circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 increase the risks of soft tissue sarcoma.
    Xu Y; Tsai CW; Chang WS; Xiong GY; Huang M; Torres KE; Bau DT; Gu J
    Am J Cancer Res; 2021; 11(8):3980-3989. PubMed ID: 34522462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
    Rosendahl AH; Forsberg G
    Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal Associations between Serum Urea and Cancer: A Mendelian Randomization Study.
    Sun Y; Li J; Qu Z; Yang Z; Jia X; Lin Y; He Q; Zhang L; Luo Y
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversial causal association between IGF family members and osteoporosis: a Mendelian randomization study between UK and FinnGen biobanks.
    Tang J; Zhao C; Lin S; Li X; Zhu B; Li Y
    Front Endocrinol (Lausanne); 2023; 14():1332803. PubMed ID: 38260127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma.
    Huang CY; Huang YL; Pu YS; Shiue HS; Chen WJ; Chen SS; Lin YC; Su CT; Hsueh YM
    Chemosphere; 2016 Jul; 154():90-98. PubMed ID: 27038904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.
    Hernandez W; Grenade C; Santos ER; Bonilla C; Ahaghotu C; Kittles RA
    Carcinogenesis; 2007 Oct; 28(10):2154-9. PubMed ID: 17724372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
    Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.